COLGATE-PALMOLIVE COMPANY (CL) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.85%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.85% | Share-based compensation / revenue. Period ending 2026-06-30. $178.00M ÷ $21.05B × 100 ≈ 0.85% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 21.05B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 178.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 3.13B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $21.05B | $178.00M | $3.13B | (m) | (m) | 0.85% | (m) | (m) |
| 2026-03-31 | (m) | $20.80B | $172.00M | $3.19B | (m) | (m) | 0.83% | (m) | (m) |
| 2025-12-31 | $366.00M | $20.38B | $155.00M | $3.31B | (m) | 1.80% | 0.76% | (m) | (m) |
| 2025-09-30 | (m) | $20.10B | $154.00M | $4.28B | (m) | (m) | 0.77% | (m) | (m) |
| 2025-06-30 | (m) | $20.00B | $147.00M | $4.29B | (m) | (m) | 0.74% | (m) | (m) |
| 2025-03-31 | (m) | $19.95B | $139.00M | $4.30B | (m) | (m) | 0.70% | (m) | (m) |
| 2024-12-31 | $355.00M | $20.10B | $135.00M | $4.27B | (m) | 1.77% | 0.67% | (m) | (m) |
| 2024-09-30 | (m) | $20.11B | $133.00M | $4.28B | (m) | (m) | 0.66% | (m) | (m) |
| 2024-06-30 | (m) | $19.99B | $128.00M | $4.24B | (m) | (m) | 0.64% | (m) | (m) |
| 2024-03-31 | (m) | $19.75B | $127.00M | $4.12B | (m) | (m) | 0.64% | (m) | (m) |
| 2023-12-31 | $343.00M | $19.46B | $122.00M | $3.98B | (m) | 1.76% | 0.63% | (m) | (m) |
| 2023-09-30 | (m) | $19.14B | $117.00M | $3.11B | (m) | (m) | 0.61% | (m) | (m) |
| 2023-06-30 | (m) | $18.68B | $117.00M | $3.03B | (m) | (m) | 0.63% | (m) | (m) |
| 2023-03-31 | (m) | $18.34B | $110.00M | $2.94B | (m) | (m) | 0.60% | (m) | (m) |
| 2022-12-31 | $320.00M | $17.97B | $125.00M | $2.89B | (m) | 1.78% | 0.70% | (m) | (m) |
| 2022-09-30 | (m) | $17.74B | $133.00M | $3.06B | (m) | (m) | 0.75% | (m) | (m) |
| 2022-06-30 | (m) | $17.70B | $122.00M | $3.08B | (m) | (m) | 0.69% | (m) | (m) |
| 2022-03-31 | (m) | $17.48B | $126.00M | $3.19B | (m) | (m) | 0.72% | (m) | (m) |
| 2021-12-31 | $307.00M | $17.42B | $135.00M | $3.33B | (m) | 1.76% | 0.77% | (m) | (m) |
| 2021-09-30 | (m) | $17.34B | $129.00M | $3.94B | (m) | (m) | 0.74% | (m) | (m) |
| 2021-06-30 | (m) | $17.08B | $133.00M | $3.99B | (m) | (m) | 0.78% | (m) | (m) |
| 2021-03-31 | (m) | $16.72B | $129.00M | $3.94B | (m) | (m) | 0.77% | (m) | (m) |
| 2020-12-31 | $290.00M | $16.47B | $107.00M | $3.88B | (m) | 1.76% | 0.65% | (m) | (m) |
| 2020-09-30 | (m) | $16.16B | $102.00M | $3.85B | (m) | (m) | 0.63% | (m) | (m) |
| 2020-06-30 | (m) | $15.94B | $98.00M | $3.69B | (m) | (m) | 0.61% | (m) | (m) |
| 2020-03-31 | (m) | $15.91B | $99.00M | $3.63B | (m) | (m) | 0.62% | (m) | (m) |
| 2019-12-31 | $281.00M | $15.69B | $100.00M | $3.55B | (m) | 1.79% | 0.64% | (m) | (m) |
| 2019-09-30 | (m) | $15.49B | $95.00M | $3.51B | (m) | (m) | 0.61% | (m) | (m) |
| 2019-06-30 | (m) | $15.41B | $96.00M | $3.53B | (m) | (m) | 0.62% | (m) | (m) |
| 2019-03-31 | (m) | $15.43B | $98.00M | $3.59B | (m) | (m) | 0.64% | (m) | (m) |
| 2018-12-31 | $277.00M | $15.54B | $109.00M | $3.69B | (m) | 1.78% | 0.70% | (m) | (m) |
| 2018-09-30 | (m) | $15.63B | $118.00M | $3.65B | (m) | (m) | 0.76% | (m) | (m) |
| 2018-06-30 | (m) | $15.75B | $121.00M | $3.73B | (m) | (m) | 0.77% | (m) | (m) |
| 2018-03-31 | (m) | $15.69B | $120.00M | $3.66B | (m) | (m) | 0.76% | (m) | (m) |
| 2017-12-31 | $285.00M | $15.45B | $127.00M | $3.59B | (m) | 1.84% | 0.82% | (m) | (m) |
| 2017-09-30 | (m) | $15.28B | $127.00M | $3.62B | (m) | (m) | 0.83% | (m) | (m) |
| 2017-06-30 | (m) | $15.18B | $128.00M | $3.76B | (m) | (m) | 0.84% | (m) | (m) |
| 2017-03-31 | (m) | $15.20B | $127.00M | $3.85B | (m) | (m) | 0.84% | (m) | (m) |
| 2016-12-31 | $289.00M | $15.20B | $123.00M | $3.84B | (m) | 1.90% | 0.81% | (m) | (m) |
| 2016-09-30 | (m) | $15.37B | $123.00M | $2.74B | (m) | (m) | 0.80% | (m) | (m) |
| 2016-06-30 | (m) | $15.51B | $122.00M | $2.81B | (m) | (m) | 0.79% | (m) | (m) |
| 2016-03-31 | (m) | $15.73B | $124.00M | $2.80B | (m) | (m) | 0.79% | (m) | (m) |
| 2015-12-31 | $274.00M | $16.03B | $125.00M | $2.79B | (m) | 1.71% | 0.78% | (m) | (m) |
| 2015-09-30 | (m) | $16.36B | $126.00M | $3.92B | (m) | (m) | 0.77% | (m) | (m) |
| 2015-06-30 | (m) | $16.74B | $128.00M | $3.73B | (m) | (m) | 0.76% | (m) | (m) |
| 2015-03-31 | (m) | $17.02B | $129.00M | $3.78B | (m) | (m) | 0.76% | (m) | (m) |
| 2014-12-31 | $277.00M | $17.28B | $131.00M | $3.56B | (m) | 1.60% | 0.76% | (m) | (m) |
| 2014-09-30 | (m) | $17.42B | $132.00M | $3.45B | (m) | (m) | 0.76% | (m) | (m) |
| 2014-06-30 | (m) | $17.44B | $130.00M | $3.52B | (m) | (m) | 0.75% | (m) | (m) |
| 2014-03-31 | (m) | $17.43B | $130.00M | $3.45B | (m) | (m) | 0.75% | (m) | (m) |
| 2013-12-31 | $267.00M | $17.42B | $128.00M | $3.56B | (m) | 1.53% | 0.73% | (m) | (m) |
| 2013-09-30 | (m) | $17.34B | $127.00M | $3.61B | (m) | (m) | 0.73% | (m) | (m) |
| 2013-06-30 | (m) | $17.28B | $124.00M | $3.62B | (m) | (m) | 0.72% | (m) | (m) |
| 2013-03-31 | (m) | $17.20B | $123.00M | $3.69B | (m) | (m) | 0.72% | (m) | (m) |
| 2012-12-31 | $259.00M | $17.09B | $120.00M | $3.89B | (m) | 1.52% | 0.70% | (m) | (m) |
| 2012-09-30 | (m) | $16.97B | $118.00M | $3.87B | (m) | (m) | 0.70% | (m) | (m) |
| 2012-06-30 | (m) | $17.02B | $114.00M | $3.88B | (m) | (m) | 0.67% | (m) | (m) |
| 2012-03-31 | (m) | $16.94B | $113.00M | $3.86B | (m) | (m) | 0.67% | (m) | (m) |
| 2011-12-31 | $262.00M | $16.73B | $122.00M | $3.84B | (m) | 1.57% | 0.73% | (m) | (m) |
| 2011-09-30 | (m) | $16.54B | (m) | $3.82B | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $16.10B | (m) | $3.75B | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $15.73B | (m) | $3.73B | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $256.00M | $15.56B | (m) | $3.49B | (m) | 1.64% | (m) | (m) | (m) |
| 2010-09-30 | (m) | $15.67B | (m) | $3.58B | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | $15.72B | (m) | $3.54B | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | $15.65B | (m) | $3.48B | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $15.33B | (m) | $3.62B | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $15.33B | (m) | $3.10B | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | $13.79B | (m) | $2.72B | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| INTERPARFUMS INC (IPAR) | United States | $3.707B | 21.36 |
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |